CD8 and CD4 are cell surface proteins expressed by mature T lymphocytes that recognize or are restricted by class I or class II major histocompatibility complex (MHC) proteins, respectively, and they play critical roles in T cell activation and differentiation. Cells expressing CD8 are mostly cytotoxic in function and are important for immune responses against viruses and tumors. CD4 cells are mostly helper/inducer in function; they provide signals for B cells to generate antibodies and serve a major regulatory role for immune responses. The overall goal of this project is to further define the parameters responsible for commitment of developing thymocytes to either the CD8 or the CD4 lineage. The first specific aim is to further define the region(s) of a CD8/CD4 hybrid (CD8alpha external, CD4 transmembrane, CD4 intracellular) transgene responsible for driving cells expressing an MHC class I- specific T cell receptor (TCR) to the CD4 lineage. This will be accomplished by generation of a series of transgenic mice expressing new CD8/CD4 hybrids and mutants. Such mice will be mated to mice expressing an MHC class I-restricted TCR transgene and the effects upon T lineage commitment of cells expressing this TCR will be examined. The second specific aim is to further determine the mechanism for low numbers of TCR transgene-expressing cells seen when the TCR and CD8/CD4 transgenes are both expressed in homozygous H-2b mice and determine whether the CD8/CD4 hybrid transgene provides increased signaling for negative selection. This will be done by generating H-2bxk heterozygous double transgenics to reduce the level by selecting class I protein by 50%. The third specific aim is to determine whether the ability of the CD8/CD4 hybrid transgene to change lineage commitment extends to other class I-specific TCRs by crossing the CD8/CD4 transgenics with mice expressing different class I-specific TCR transgenes. The double transgenic progeny will be analyzed for T cell and thymocyte subsets. The final goal is to determine the functional program of the CD4 cells bearing the class I-restricted TCR transgene in mice expressing both the hybrid CD8/CD4 and the TCR transgene by examining whether these cells have a T helper cell phenotype.

Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1996
Total Cost
Indirect Cost
Pogue, S L; Goodnow, C C (2000) Gene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors. J Exp Med 191:1031-44
Frank, G D; Parnes, J R (1998) The level of CD4 surface protein influences T cell selection in the thymus. J Immunol 160:634-42
Zhang, X L; Seong, R; Piracha, R et al. (1998) Distinct stage-specific cis-active transcriptional mechanisms control expression of T cell coreceptor CD8 alpha at double- and single-positive stages of thymic development. J Immunol 161:2254-66
Messika, E J; Lu, P S; Sung, Y J et al. (1998) Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. J Exp Med 188:515-25
Townsend, S E; Goodnow, C C (1998) Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo. J Exp Med 187:1611-21
Akkaraju, S; Canaan, K; Goodnow, C C (1997) Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells. J Exp Med 186:2005-12
Akkaraju, S; Ho, W Y; Leong, D et al. (1997) A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 7:255-71
Reich, Z; Altman, J D; Boniface, J J et al. (1997) Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins. Proc Natl Acad Sci U S A 94:2495-500
Conboy, I M; DeKruyff, R H; Tate, K M et al. (1997) Novel genetic regulation of T helper 1 (Th1)/Th2 cytokine production and encephalitogenicity in inbred mouse strains. J Exp Med 185:439-51
Fournier, S; Rathmell, J C; Goodnow, C C et al. (1997) T cell-mediated elimination of B7.2 transgenic B cells. Immunity 6:327-39

Showing the most recent 10 out of 77 publications